INEL BNCT research program, July--August 1992
This report presents summaries for two months of current research of the Idaho National Engineering Laboratory (INEL) Boron Neutron Capture Therapy (BNCT) Program. Information is presented on development and murine screening experiments of low-density lipoprotein, carboranyl alanine, and liposome boron containing compounds. Pituitary tumor cell culture studies are described. Drug stability, pharmacology and toxicity evaluation of borocaptate sodium (BSH) and boronophenylalanine (BPA) are described. Treatment protocol development via the large animal (canine) model studies and physiological response evaluation in rats are discussed. Supporting technology development and technical support activities for boron drug biochemistry and purity, analytical and measurement dosimetry, and noninvasive boron quantification activities are included for the current time period. Current publications for the two months are listed.
- Research Organization:
- EG and G Idaho, Inc., Idaho Falls, ID (United States)
- Sponsoring Organization:
- USDOE; USDOE, Washington, DC (United States)
- DOE Contract Number:
- AC07-76ID01570
- OSTI ID:
- 7120497
- Report Number(s):
- EGG-BNCT-10016; ON: DE93005236
- Country of Publication:
- United States
- Language:
- English
Similar Records
INEL BNCT Research Program, January/February 1993
INEL BNCT Research Program, March/April 1992
Related Subjects
NEUTRON THERAPY
RADIOPHARMACEUTICALS
TISSUE DISTRIBUTION
TOXICITY
LIPOPROTEINS
LIPOSOMES
ORGANIC BORON COMPOUNDS
PHENYLALANINE
AMINO ACIDS
BORON COMPOUNDS
CARBOXYLIC ACIDS
DISTRIBUTION
DRUGS
LABELLED COMPOUNDS
LIPIDS
MEDICINE
NUCLEAR MEDICINE
ORGANIC ACIDS
ORGANIC COMPOUNDS
PROTEINS
RADIOLOGY
RADIOTHERAPY
THERAPY
550603* - Medicine- External Radiation in Therapy- (1980-)